Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Foghorn Therapeutics (FHTX) Preferred Shares Issued (2020)

Foghorn Therapeutics has reported Preferred Shares Issued over the past 1 years, most recently at $41.9 million for Q3 2020.

  • Quarterly results put Preferred Shares Issued at $41.9 million for Q3 2020, changed N/A from a year ago — trailing twelve months through Dec 2021 was $41.9 million (changed N/A YoY), and the annual figure for FY2020 was $89.9 million, up 487.56%.
  • Preferred Shares Issued for Q3 2020 was $41.9 million at Foghorn Therapeutics.
  • Over the last five years, Preferred Shares Issued for FHTX hit a ceiling of $41.9 million in Q3 2020 and a floor of $41.9 million in Q3 2020.